Clinical Trial Update: Dipeptidyl Peptidase-4 Inhibition and Immune Function in HIV [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating DPP-4 inhibition and immune function in HIV patients with diabetes and insulin resistance; results were posted in 2014 after completi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Insulin Resistance

Drugs mentioned

• DPP-4 inhibitor

Snippet

Sponsor: Washington University School of Medicine | Conditions: Diabetes, Insulin Resistance | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-01-23